[325] suggested that TET1 has a tumor suppressor effect in ovarian cancer because TET1 inhibits typical Wnt/β‐catenin signaling by activating the signaling inhibitors DKK and secreted Fzd receptor protein 2, which suppresses EMT and metastasis of the cancer cells. This evidence concerns the gene TET1 and ovarian carcinoma.